This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.
Research
Latest papers
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy
Radiotherapy and Oncology · 2024
How current assay approval policies are leading to unintended imprecision medicine.
The Lancet. Oncology · 2020
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
Clinical breast cancer · 2020
Latest funding
- $948,600
Deciphering Immune Evasion in Synovial Sarcoma through Interpretable AI and Validation Experiments
CIHR · 2026 · Co-investigator
- $105,000
Drug Targeting Drivers of Synovial Sarcoma Development
CIHR · 2023 · Supervisor
- $948,600
Translating Epigenomics into Clinical Care for Synovial Sarcoma
CIHR · 2023 · Nominated PI
13 publications.
LUMINA: Using molecular biomarkers to guide decision making for breast radiotherapy
Whelan TJ, Fyles A, Parpia S, Nielsen T, Levine MN
How current assay approval policies are leading to unintended imprecision medicine.
Salgado R, Bellizzi AM, Rimm D, Bartlett JMS, Nielsen T, Holger M, Laenkholm AV, Quinn C, Cserni G, Cunha IW, Alvarado-Cabrero I, Cree I
Population-based Study of Prosigna-PAM50 and Outcome Among Postmenopausal Women With Estrogen Receptor-positive and HER2-negative Operable Invasive Lobular or Ductal Breast Cancer.
Lænkholm AV, Jensen MB, Eriksen JO, Roslind A, Buckingham W, Ferree S, Nielsen T, Ejlertsen B
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.
Dieci MV, Radosevic-Robin N, Fineberg S, van den Eynden G, Ternes N, Penault-Llorca F, Pruneri G, D'Alfonso TM, Demaria S, Castaneda C, Sanchez J, Badve S, Michiels S, Bossuyt V, Rojo F, Singh B, Nielsen T, Viale G, Kim SR, Hewitt S, Wienert S, Loibl S, Rimm D, Symmans F, Denkert C, Adams S, Loi S, Salgado R, International Immuno-Oncology Biomarker Working Group on Breast Cancer
Intrinsic subtypes and benefit from postmastectomy radiotherapy in node-positive premenopausal breast cancer patients who received adjuvant chemotherapy - results from two independent randomized trials.
Laurberg T, Tramm T, Nielsen T, Alsner J, Nord S, Myhre S, Sørlie T, Leung S, Fan C, Perou C, Gelmon K, Overgaard J, Voduc D, Prat A, Cheang MCU
Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors.
Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB
Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research.
Hendry S, Salgado R, Gevaert T, Russell PA, John T, Thapa B, Christie M, van de Vijver K, Estrada MV, Gonzalez-Ericsson PI, Sanders M, Solomon B, Solinas C, Van den Eynden GGGM, Allory Y, Preusser M, Hainfellner J, Pruneri G, Vingiani A, Demaria S, Symmans F, Nuciforo P, Comerma L, Thompson EA, Lakhani S, Kim SR, Schnitt S, Colpaert C, Sotiriou C, Scherer SJ, Ignatiadis M, Badve S, Pierce RH, Viale G, Sirtaine N, Penault-Llorca F, Sugie T, Fineberg S, Paik S, Srinivasan A, Richardson A, Wang Y, Chmielik E, Brock J, Johnson DB, Balko J, Wienert S, Bossuyt V, Michiels S, Ternes N, Burchardi N, Luen SJ, Savas P, Klauschen F, Watson PH, Nelson BH, Criscitiello C, O'Toole S, Larsimont D, de Wind R, Curigliano G, André F, Lacroix-Triki M, van de Vijver M, Rojo F, Floris G, Bedri S, Sparano J, Rimm D, Nielsen T, Kos Z, Hewitt S, Singh B, Farshid G, Loibl S, Allison KH, Tung N, Adams S, Willard-Gallo K, Horlings HM, Gandhi L, Moreira A, Hirsch F, Dieci MV, Urbanowicz M, Brcic I, Korski K, Gaire F, Koeppen H, Lo A, Giltnane J, Rebelatto MC, Steele KE, Zha J, Emancipator K, Juco JW, Denkert C, Reis-Filho J, Loi S, Fox SB
ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016.
Dittrich C, Kosty M, Jezdic S, Pyle D, Berardi R, Bergh J, El-Saghir N, Lotz JP, Österlund P, Pavlidis N, Purkalne G, Awada A, Banerjee S, Bhatia S, Bogaerts J, Buckner J, Cardoso F, Casali P, Chu E, Close JL, Coiffier B, Connolly R, Coupland S, De Petris L, De Santis M, de Vries EG, Dizon DS, Duff J, Duska LR, Eniu A, Ernstoff M, Felip E, Fey MF, Gilbert J, Girard N, Glaudemans AW, Gopalan PK, Grothey A, Hahn SM, Hanna D, Herold C, Herrstedt J, Homicsko K, Jones DV, Jost L, Keilholz U, Khan S, Kiss A, Köhne CH, Kunstfeld R, Lenz HJ, Lichtman S, Licitra L, Lion T, Litière S, Liu L, Loehrer PJ, Markham MJ, Markman B, Mayerhoefer M, Meran JG, Michielin O, Moser EC, Mountzios G, Moynihan T, Nielsen T, Ohe Y, Öberg K, Palumbo A, Peccatori FA, Pfeilstöcker M, Raut C, Remick SC, Robson M, Rutkowski P, Salgado R, Schapira L, Schernhammer E, Schlumberger M, Schmoll HJ, Schnipper L, Sessa C, Shapiro CL, Steele J, Sternberg CN, Stiefel F, Strasser F, Stupp R, Sullivan R, Tabernero J, Travado L, Verheij M, Voest E, Vokes E, Von Roenn J, Weber JS, Wildiers H, Yarden Y
Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS
Analytical validation of the PAM50-based Prosigna Breast Cancer Prognostic Gene Signature Assay and nCounter Analysis System using formalin-fixed paraffin-embedded breast tumor specimens.
Nielsen T, Wallden B, Schaper C, Ferree S, Liu S, Gao D, Barry G, Dowidar N, Maysuria M, Storhoff J
Deciphering Immune Evasion in Synovial Sarcoma through Interpretable AI and Validation Experiments
Principal investigators: Tang, Xin; Underhill, Michael
Keywords: Ai For Cancer Genomics; Bioinformatics; Cd24/Cd24a; Immune Evasion; Immune-Cold Tumours; Interpretable Ai; Machine Learning For Biomedicine; Mesenchymal Stromal Cells; Single-Cell And Spatial Omics; Synovial Sarcoma
Drug Targeting Drivers of Synovial Sarcoma Development
Principal investigators: Wang, Xue Q
Keywords: Chemotherapeutics; Mouse Drug Models]; Single Cell Rna Sequencing; Synovial Sarcoma; Transcriptomics
Translating Epigenomics into Clinical Care for Synovial Sarcoma
Principal investigators: Nielsen, Torsten O
Keywords: Baf; Conditional Mouse Model; Erna; Fusion Oncoprotein; Sarcoma
Optimizing triple negative breast cancer therapy based on immune cell morphology
Principal investigators: Nielsen, Torsten O
Keywords: Breast Cancer; Imaging Technologies; Targets And Biomarkers; Translational Research
Translating Epigenomics into Clinical Care for Synovial Sarcoma
Principal investigators: Nielsen, Torsten O
Keywords: Baf Complex; Conditional Mouse Model; Epigenetic Therapy; Erna; Fusion Oncoprotein; Gene Transcription; Mesenchyme; Sarcoma
Proteomic identification of clinically-important subgroups among basal-like breast cancer
Principal investigators: Asleh Abu Raya, Karama
Keywords: Basal-Like; Biomarkers; Breast Cancer; Formalin-Pixed-Paraffin-Embedded Tissue; Gene Expression; Immunohistochemistry; Intrinsic Subtyping; Pam50; Proteomics; Targeted Therapy
DCIS-Precise: A Genomics-Driven Model for Predicting DCIS Response to Radiation
Principal investigators: Rakovitch, Eileen; Hallett, Michael T
Keywords: Biomarkers; Breast Cancer; Dcis; Genomic Assay; Prediction; Radiation Treatment
A Randomized Trial of Regional Radiotherapy in Luminal A Breast Cancer
Principal investigators: Whelan, Timothy J
Keywords: Biomarkers; Breast Cancer; Radiation Therapy
Avoidance of Radiotherapy in Luminal A Breast Cancer
Principal investigators: Whelan, Timothy J; Fyles, Anthony W; Liu, Fei-Fei
Keywords: Breast Cancer; Cohort Study; Instrinsic Subtypes; Radiotherapy
CSF1 pathway inhibitors in tenosynovial giant cell tumors and leiomyosarcoma
Principal investigators: Nielsen, Torsten O
Keywords: Csf1; Experimental Therapeutics; Macrophage; Sarcoma; Soft Tissue Tumors; Transgenic Mouse; Xenograft
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Timothy Whelan and Mark Norman Levine: 133 shared papers
- Sameer Parpia and Mark Norman Levine: 57 shared papers
- Sameer Parpia and Timothy Whelan: 47 shared papers
- Torsten Nielsen and Zuzana Kos: 2 shared papers
- Sameer Parpia and Torsten Nielsen: 1 shared paper
- Sameer Parpia and Zuzana Kos: 1 shared paper
- Timothy Whelan and Torsten Nielsen: 1 shared paper
- Timothy Whelan and Zuzana Kos: 1 shared paper
- Mark Norman Levine and Torsten Nielsen: 1 shared paper
- Martin Hirst and Torsten Nielsen: 1 shared paper
- Oncology
- Pathology and Laboratory Medicine
- Microbiology and Immunology
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.